Related content

Using Biologic Agents in Pediatric Rheumatologic Diseases

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 1, 2010-01 ,pp. : 41-45

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Dosing During Intermittent Hemodialysis and Continuous Renal Replacement Therapy: Special Considerations in Pediatric Patients

By Veltri M.A.  

Pediatric Drugs, Vol. 6, Iss. 1, 2004-01 ,pp. : 45-65

Adis International

Access to resources Recommend Favorite

Anti-Interleukin-2 Receptor Antibodies for the Prevention of Rejection in Pediatric Renal Transplant Patients: Current Status

By Swiatecka-Urban A.  

Pediatric Drugs, Vol. 5, Iss. 10, 2003-01 ,pp. : 699-716

Adis International

Access to resources Recommend Favorite

Management of Pediatric Patients with CRPS

By Olsson Gunnar L.  

Journal of Neuropathic Pain & Symptom Palliation, Vol. 2, Iss. 3, 2007-12 ,pp. : 25-28

Haworth Press

Access to resources Recommend Favorite

Cost-effectiveness of Oral Clodronate Compared with Oral Ibandronate, Intravenous Zoledronate or Intravenous Pamidronate in Breast Cancer Patients

By Paterson A   McCloskey E   Redzepovic J   Ott I   Gust R  

The Journal of International Medical Research, Vol. 36, Iss. 3, 2008-05 ,pp. : 400-413

Field House Publishing

Access to resources Recommend Favorite